STOCK TITAN

Monro (MNRO) Financials

MNRO NASDAQ
Trailing 12 months to September 26, 2026
Revenue $1.1B -4.4% YoY
Net Income $798K n/m YoY
EPS (Diluted) -$0.01 n/m YoY
Free Cash Flow $12.4M -74.4% YoY
Market Cap $315.5M as of Nov 17, 2026
Price / Sales 0.3x on $1.1B revenue, trailing 12 months to September 26, 2026
Price / Earnings 395x on $798K net income, trailing 12 months to September 26, 2026
Price / Book 0.5x on $573.9M equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Sep 26, 2026 Reported Currency USD FYE March

Newest figures come from the 10-Q for Q2 FY2027, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MNRO SEC filings page.

Monro, Inc. (MNRO) reported $1.1B in revenue over the twelve months to Sep 26, 2026, down 4.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MNRO FY2026

Monro’s gross margin remains broadly stable, but operating profit and free cash flow have weakened as short-term obligations exceed current assets.

Revenue fell -12.7% from FY2023 to FY2026 even as gross margin improved 0.6 percentage points; operating income fell 74.9%, showing that costs below gross profit absorbed much of the business’s economics. Over the same span, operating cash flow fell 67.2% while free cash flow fell 78.0%, indicating that cash generation weakened faster than sales.

FY2026 current assets were $237M versus $518M of current liabilities, leaving a short-term funding gap despite a relatively low debt-to-equity ratio of 0.1x. Long-term debt was $60M against total liabilities of $977M, so the balance-sheet pressure is not primarily conventional borrowing.

FY2026’s $38.8M of free cash flow sat only slightly above $35.0M of dividends, leaving little internally generated cash after distributions. The operating margin recovered to 1.7% from 1.1%, but that improvement still represents thin operating profitability rather than substantial financial flexibility.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 37 / 100
Financial Health Score 37/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Monro, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
38

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Monro, Inc. scores 38/100 on it among other operating companies.

Growth
17

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Monro, Inc. scores 17/100 on it among other operating companies.

Leverage
67

Monro, Inc.'s net debt of $45.4M, being $60.0M of long-term debt less $14.6M of cash, came to 0.56 times its EBITDA in fiscal year 2026. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Monro, Inc. scores 67/100 among other operating companies measured the same way.

Liquidity
4

Monro, Inc. held $0.46 of current assets for every $1 of current liabilities at the end of fiscal year 2026, a current ratio of 0.46. Liquidity ranks operating companies on that ratio, and Monro, Inc. scores 4/100 among other operating companies.

Cash Flow
50

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Monro, Inc. scores 50/100 on it among other operating companies.

Returns
43

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Monro, Inc. scores 43/100 on it among other operating companies.

Altman Z-Score Distress
1.28

Monro, Inc. scores 1.28, below the 1.81 distress threshold. The score is pulled down most by current liabilities exceeding current assets by $281.2M against total assets of $1.6B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Monro, Inc. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
N/A

Monro, Inc. reported $2.2M of net income while generating $70.4M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$283.6M
YoY-1.8%
QoQ-1.2%
5Y CAGR-4.0%
10Y CAGR+1.4%

Monro, Inc. generated $283.6M in revenue in Q2 2027. This represents a decrease of 1.8% from the same quarter a year earlier. Against the prior quarter it is down 1.2%.

EBITDA
$17.9M
YoY-36.3%
QoQ-7.7%
5Y CAGR-20.0%
10Y CAGR-8.3%

Monro, Inc.'s EBITDA was $17.9M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 36.3% from the same quarter a year earlier. Against the prior quarter it is down 7.7%.

Net Income
-$1.6M
YoY-128.4%
QoQn/m

Monro, Inc. reported a net loss of $1.6M in Q2 2027. This represents a decrease of 128.4% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.05
YoY-127.8%
QoQn/m

Monro, Inc. earned -$0.05 per diluted share (EPS) in Q2 2027. This represents a decrease of 127.8% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
$28.8M
YoY+8.2%
QoQn/m
5Y CAGR-3.7%
10Y CAGR-2.3%

Monro, Inc. generated $28.8M in free cash flow in Q2 2027, representing cash available after capex. This represents an increase of 8.2% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$15.0M
YoY+42.9%
QoQ+57.0%
5Y CAGR+17.6%
10Y CAGR+7.5%

Monro, Inc. held $15.0M in cash against $100.0M in long-term debt as of Q2 2027.

Dividends Per Share
$0.28
YoY0.0%
QoQ0.0%

Monro, Inc. paid $0.28 per share in dividends in Q2 2027. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
31M
YoY+4.4%
QoQ+0.2%

Monro, Inc. had 31M shares outstanding in Q2 2027. This represents an increase of 4.4% from the same quarter a year earlier. Against the prior quarter it is up 0.2%.

Margins & Returns

Gross Margin
35.2%
YoY-0.5pp
QoQ+0.3pp
5Y change-2.4pp
10Y change-5.4pp

Monro, Inc.'s gross margin was 35.2% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin
0.9%
YoY-3.5pp
QoQ-0.4pp
5Y change-9.0pp
10Y change-12.1pp

Monro, Inc.'s operating margin was 0.9% in Q2 2027, reflecting core business profitability. This is down 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Net Margin
-0.6%
YoY-2.5pp
QoQ+0.2pp
5Y change-6.6pp
10Y change-7.7pp

Monro, Inc.'s net profit margin was -0.6% in Q2 2027, showing the share of revenue converted to profit. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Return on Equity
-0.3%
YoY-1.2pp
QoQ+0.1pp
5Y change-3.0pp
10Y change-3.4pp

Monro, Inc.'s quarterly ROE was -0.3% in Q2 2027: one quarter's net income over shareholder equity, not annualized. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Capital Allocation

Capital Expenditures
$5.8M
YoY+1.3%
QoQ-23.0%
5Y CAGR+3.7%
10Y CAGR-5.2%

Monro, Inc. invested $5.8M in capex in Q2 2027, funding long-term assets and infrastructure. This represents an increase of 1.3% from the same quarter a year earlier. Against the prior quarter it is down 23.0%.

R&D Spending

Not reported for Q2 2027.

Share Buybacks

Not reported for Q2 2027.

MNRO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MNRO quarterly income statement
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Revenue$283.6M-1.8%$287.1M-4.6%$273.8M-7.2%$293.4M-4.0%$288.9M-4.1%$301.0M+2.7%$295.0M-4.9%$305.8M-3.7%
Gross Profit$99.9M-3.1%$100.4M-6.1%$92.9M-4.5%$102.4M-2.3%$103.1M-3.1%$106.9M-2.1%$97.3M-11.6%$104.8M-7.0%
Operating Income$2.6M-79.7%$3.7Mn/m-$5.2Mn/m$18.6M+86.4%$12.8M-3.4%-$6.1M-145.9%-$23.8M-330.7%$10.0M-53.4%
EBITDA$17.9M-36.3%$19.3M+103.3%$10.3Mn/m$33.9M+25.0%$28.0M-8.7%$9.5M-69.3%-$6.8M-124.3%$27.1M-31.1%
Income Tax-$330K-111.9%$153Kn/m-$2.6Mn/m$3.4M+178.5%$2.8M+9.6%-$2.7M-213.7%-$6.8M-442.9%$1.2M-70.8%
Net Income-$1.6M-128.4%-$2.1Mn/m-$6.6Mn/m$11.1M+143.1%$5.7M+0.3%-$8.1M-237.3%-$21.3M-675.0%$4.6M-62.3%
EPS (Basic)-$0.05-127.8%-$0.08n/m-$0.23n/m$0.36+140.0%$0.180.0%-$0.28-247.4%-$0.74-716.7%$0.15-60.5%
EPS (Diluted)-$0.05-127.8%-$0.08n/m-$0.23n/m$0.35+133.3%$0.180.0%-$0.28-247.4%-$0.74-669.2%$0.15-60.5%
Diluted Shares (Avg)31M-0.2%30M+0.6%N/A31M+0.4%31M+0.4%30M-4.0%N/A31M-2.8%

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses, SG&A Expenses, Interest Expense.

MNRO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MNRO quarterly balance sheet
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Total Assets$1.5B-2.5%$1.6B-3.0%$1.6B-4.5%$1.6B-6.0%$1.6B-5.8%$1.6B-6.3%$1.6B-3.0%$1.7B-3.6%
Current Assets$233.6M-3.8%$231.7M-9.1%$236.6M-14.7%$228.8M-16.4%$242.8M-9.0%$254.8M-8.4%$277.4M+9.5%$273.7M+0.7%
Cash & Equivalents$15.0M+42.9%$9.5M+22.1%$14.6M-29.5%$4.9M-51.7%$10.5M-49.8%$7.8M-58.2%$20.8M+216.4%$10.2M-57.4%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$155.4M-3.3%$156.2M-9.1%$155.3M-14.4%$153.3M-13.2%$160.7M-0.8%$171.9M+5.9%$181.5M+17.8%$176.5M+10.1%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$736.4M0.0%$736.4M0.0%$736.4M0.0%$736.4M0.0%$736.4M0.0%$736.4M0.0%$736.4M0.0%$736.4M0.0%
Total Liabilities$971.2M-1.1%$974.0M-2.6%$976.5M-4.4%$965.0M-5.5%$982.3M-4.6%$1.0B-5.4%$1.0B-1.4%$1.0B-4.9%
Current Liabilities$491.3M-3.9%$472.9M-6.5%$517.8M-1.2%$503.3M-0.9%$511.2M+1.9%$506.0M+8.0%$524.3M+15.2%$507.7M+4.3%
Non-Current Liabilities$479.9M+1.9%$501.1M+1.4%$458.7M-7.7%$461.7M-10.1%$471.1M-10.7%$494.2M-16.1%$496.8M-14.5%$513.3M-12.5%
Long-Term Debt$100.0M+66.7%$108.4M+51.6%$60.0M-2.0%$45.0M-24.1%$60.0M-3.2%$71.5M-36.1%$61.3M-40.0%$59.3M-37.0%
Total Equity$573.9M-4.6%$582.5M-3.7%$591.5M-4.7%$604.9M-6.8%$601.7M-7.7%$604.9M-7.6%$620.8M-5.5%$648.9M-1.6%
Retained Earnings$560.0M-5.9%$570.6M-4.6%$581.7M-5.4%$597.2M-7.4%$595.0M-8.4%$598.3M-8.3%$615.1M-6.2%$645.1M-2.3%

Not reported in any period shown, so not listed: Accounts Receivable.

MNRO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MNRO quarterly cash flow statement
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Operating Cash Flow$34.6M+7.0%-$30.4Mn/m$22.2M-23.2%$17.8M+20.5%$32.3M-48.3%-$1.9M-107.6%$28.9Mn/m$14.8M-54.0%
Depreciation & Amortization$15.3M0.0%$15.7M+0.4%$15.5M-8.7%$15.3M-10.7%$15.3M-12.7%$15.6M-12.1%$17.0M-4.3%$17.1M-4.3%
Stock-Based CompensationN/A$1.6M+66.3%N/AN/AN/A$984K+48.2%N/AN/A
Capital Expenditures$5.8M+1.3%$7.5M+1.8%$9.8M+72.8%$8.7M+26.5%$5.7M+16.5%$7.4M-16.7%$5.7M-13.7%$6.9M+115.8%
Free Cash Flow$28.8M+8.2%-$37.9Mn/m$12.4M-46.7%$9.1M+15.3%$26.6M-53.8%-$9.3M-155.7%$23.2Mn/m$7.9M-72.7%
Investing Cash Flow-$2.7Mn/m-$4.5Mn/m-$8.2Mn/m$9.4Mn/m-$45K-100.5%-$2.4Mn/m-$1.3Mn/m-$4.5M-170.9%
Financing Cash Flow-$26.5Mn/m$29.8Mn/m-$4.3Mn/m-$32.8Mn/m-$29.6Mn/m-$8.7Mn/m-$17.0Mn/m-$21.0Mn/m
Dividends Paid$8.8M+0.3%$8.7M+0.2%$8.7M-3.5%$8.7M+4.3%$8.7M+0.2%$8.7M+0.2%$9.1M+4.0%$8.4M-6.2%

Not reported in any period shown, so not listed: Share Buybacks.

MNRO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MNRO quarterly financial ratios
MetricQ2'2710-QQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Gross Margin35.2%-0.5pp35.0%-0.5pp33.9%+0.9pp34.9%+0.6pp35.7%+0.4pp35.5%-1.7pp33.0%-2.5pp34.3%-1.2pp
Operating Margin0.9%-3.5pp1.3%+3.3pp-1.9%+6.2pp6.3%+3.1pp4.4%0.0pp-2.0%-6.5pp-8.1%-11.4pp3.3%-3.5pp
Net Margin-0.6%-2.5pp-0.8%+1.9pp-2.4%+4.8pp3.8%+2.3pp2.0%+0.1pp-2.7%-4.7pp-7.2%-8.4pp1.5%-2.3pp
Return on Equity-0.3%-1.2pp-0.4%+1.0pp-1.1%+2.3pp1.8%+1.1pp0.9%+0.1pp-1.3%-2.2pp-3.4%-4.0pp0.7%-1.1pp
Return on Assets-0.1%-0.5pp-0.1%+0.4pp-0.4%+0.9pp0.7%+0.4pp0.4%0.0pp-0.5%-0.8pp-1.3%-1.5pp0.3%-0.4pp
Current Ratio0.480.0x0.490.0x0.46-0.1x0.45-0.1x0.48-0.1x0.50-0.1x0.530.0x0.540.0x
Debt-to-Equity0.17+0.1x0.19+0.1x0.100.0x0.070.0x0.100.0x0.12-0.1x0.10-0.1x0.09-0.1x
Liabilities-to-Equity1.69+0.1x1.670.0x1.650.0x1.600.0x1.63+0.1x1.650.0x1.64+0.1x1.57-0.1x
Asset Turnover0.180.0x0.180.0x0.170.0x0.190.0x0.180.0x0.190.0x0.180.0x0.180.0x
FCF Margin10.2%+0.9pp-13.2%-10.1pp4.5%-3.4pp3.1%+0.5pp9.2%-9.9pp-3.1%-8.8pp7.9%+11.7pp2.6%-6.5pp

Note: The current ratio is below 1.0 (0.46), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Monro, Inc. MNRO FY2026 $1.2B $2.2M 0.2% $315.5M 37/100
Cooper-Standard Automotive Inc. CPS FY2025 $2.7B -$4.2M -0.1% $323.8M 29/100
ECARX Holdings Inc. ECX FY2025 $847.9M -$66.0M -7.8% $306.5M 25/100
Solid Power, Inc. SLDP FY2025 $21.7M -$93.4M N/A $357.5M 66/100
Holley Inc. HLLY FY2025 $613.5M $19.2M 3.1% $299.3M 47/100
Miller Industries, Inc. MLR FY2025 $790.3M $23.0M 2.9% $534.8M 57/100

Frequently Asked Questions

Monro, Inc. (MNRO) reported $1.2B in total revenue for fiscal year 2026. This represents a -3.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Monro, Inc. (MNRO) revenue declined by 3.2% year-over-year, from $1.2B to $1.2B in fiscal year 2026.

Yes, Monro, Inc. (MNRO) reported a net income of $798K over the trailing 12 months to September 26, 2026. In fiscal year 2026 it reported a net income of $2.2M, with a net profit margin of 0.2%.

Monro, Inc. (MNRO) reported diluted earnings per share of $0.03 for fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Monro, Inc. (MNRO) had EBITDA of $81.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, Monro, Inc. (MNRO) had $14.6M in cash and equivalents against $60.0M in long-term debt.

Monro, Inc. (MNRO) had a gross margin of 35.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Monro, Inc. (MNRO) had an operating margin of 1.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Monro, Inc. (MNRO) had a net profit margin of 0.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Yes, Monro, Inc. (MNRO) paid $1.12 per share in dividends during fiscal year 2026.

Monro, Inc. (MNRO) has a return on equity of 0.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Monro, Inc. (MNRO) generated $38.8M in free cash flow during fiscal year 2026. This represents a -63.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Monro, Inc. (MNRO) generated $70.4M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Monro, Inc. (MNRO) had $1.6B in total assets as of fiscal year 2026, including both current and long-term assets.

Monro, Inc. (MNRO) invested $31.7M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Monro, Inc. (MNRO) had 30M shares outstanding as of fiscal year 2026.

Monro, Inc. (MNRO) had a current ratio of 0.46 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

Monro, Inc. (MNRO) had a debt-to-equity ratio of 0.10 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Monro, Inc. (MNRO) had a liabilities-to-equity ratio of 1.65 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Monro, Inc. (MNRO) had a return on assets of 0.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Monro, Inc. (MNRO) trades at 395x earnings, its market capitalization divided by $798K net income, trailing 12 months to September 26, 2026. The market capitalization is $315.5M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Monro, Inc. (MNRO) trades at 0.3x sales, its market capitalization divided by $1.1B revenue, trailing 12 months to September 26, 2026. The market capitalization is $315.5M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Monro, Inc. (MNRO) has an Altman Z-Score of 1.28, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Monro, Inc. (MNRO) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Monro, Inc. (MNRO) reported $2.2M of net income while generating $70.4M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Monro, Inc. (MNRO) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top